Matches in Wikidata for { <http://www.wikidata.org/entity/Q59319957> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q59319957 description "article scientifique publié en 2014" @default.
- Q59319957 description "im Jahr 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59319957 description "wetenschappelijk artikel" @default.
- Q59319957 description "наукова стаття, опублікована у 2014" @default.
- Q59319957 name "Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma" @default.
- Q59319957 name "Phase II study of autologous mRNA electroporated dendritic cells" @default.
- Q59319957 type Item @default.
- Q59319957 label "Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma" @default.
- Q59319957 label "Phase II study of autologous mRNA electroporated dendritic cells" @default.
- Q59319957 prefLabel "Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma" @default.
- Q59319957 prefLabel "Phase II study of autologous mRNA electroporated dendritic cells" @default.
- Q59319957 P1433 Q59319957-7EB1F355-29A9-4709-897A-D69E7EEC036E @default.
- Q59319957 P1476 Q59319957-9893CCBC-03F7-45B8-8F19-1B0BF13B2AC4 @default.
- Q59319957 P2093 Q59319957-0CCD600D-B14D-47D9-8565-E6DD0B18E337 @default.
- Q59319957 P2093 Q59319957-51D6677D-1906-42EB-AD32-F3017C274D13 @default.
- Q59319957 P2093 Q59319957-58CABE8F-FA4C-40AC-9E0C-46C4CE67FD9B @default.
- Q59319957 P2093 Q59319957-AAB2E268-8095-4F83-A05C-2AF2845C27E1 @default.
- Q59319957 P2093 Q59319957-DC968E38-68D2-4C03-9192-EAC82EA273A2 @default.
- Q59319957 P2888 Q59319957-6AD48C8C-1EBD-46DC-9129-827273267DF2 @default.
- Q59319957 P304 Q59319957-E28A2589-7499-4456-8163-9A2403D37720 @default.
- Q59319957 P31 Q59319957-B0F81076-CC38-4CA0-8386-4DEA3274E355 @default.
- Q59319957 P356 Q59319957-4F90EFE1-A0C6-43DD-97F4-D135D3B3D664 @default.
- Q59319957 P433 Q59319957-D1901F92-102A-4859-8787-7AA1C07DD78C @default.
- Q59319957 P478 Q59319957-DEFF9C4F-D1C2-41DD-9260-AC606D80EB68 @default.
- Q59319957 P577 Q59319957-18113B2C-B4A2-4E70-9003-8FE476EE1A8E @default.
- Q59319957 P6179 Q59319957-47E1140A-5A6E-474D-9422-E7D7BC4EFA1C @default.
- Q59319957 P921 Q59319957-BDA844E6-7928-4CF8-8F6A-31E4B57C37EC @default.
- Q59319957 P921 Q59319957-E4282BD2-DCCE-4646-AFBD-70D8CC0418A9 @default.
- Q59319957 P932 Q59319957-6213AE92-AB4E-4EF1-97A2-C70082A4A207 @default.
- Q59319957 P356 2051-1426-2-S3-P129 @default.
- Q59319957 P1433 Q27725163 @default.
- Q59319957 P1476 "Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma" @default.
- Q59319957 P2093 "Bart Neyns" @default.
- Q59319957 P2093 "Carlo Heirman" @default.
- Q59319957 P2093 "Jurgen Corthals" @default.
- Q59319957 P2093 "Kris Thielemans" @default.
- Q59319957 P2093 "Sofie Wilgenhof" @default.
- Q59319957 P2888 2051-1426-2-s3-p129 @default.
- Q59319957 P304 "P129" @default.
- Q59319957 P31 Q13442814 @default.
- Q59319957 P356 "10.1186/2051-1426-2-S3-P129" @default.
- Q59319957 P433 "Suppl 3" @default.
- Q59319957 P478 "2" @default.
- Q59319957 P577 "2014-01-01T00:00:00Z" @default.
- Q59319957 P6179 "1029969462" @default.
- Q59319957 P921 Q1142521 @default.
- Q59319957 P921 Q506253 @default.
- Q59319957 P932 "4288437" @default.